Cannabis stocks TLRY, CGC, ACB, and the MSOS ETF fell 2-5.5% after an early rally. The DOJ is reclassifying medical marijuana to Schedule III, reducing red tape and taxes per US President Donald Trump's order. Retail sentiment calls the industry "reborn", though recreational use isn't legalised.